PharmaEngine Company Description

PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan and Europe.

It offers ONIVYDE, a novel and stable encapsulated chemotherapy drug irinotecan for the treatment of metastatic pancreatic cancer and other indications of clinical development.

The company is developing PEP07, a checkpoint kinase 1 inhibitor, which is in preclinical development stage for the treatment of hematologic cancers and solid cancers, such as acute myeloid leukemia and mantle cell lymphoma.

PharmaEngine, Inc. was incorporated in 2002 and is headquartered in Taipei, Taiwan.

PharmaEngine, Inc.

Country	Taiwan
Founded	2002
Industry	Biotechnology
Sector	Healthcare
CEO	Hong-Ren Wang

Contact Details

Address: 10 Minsheng East Road Taipei, 104 Taiwan
Phone	886 2 2515 8228
Website	pharmaengine.com

Stock Details

Ticker Symbol	4162
Exchange	Taipei Exchange
Fiscal Year	January - December
Reporting Currency	TWD
ISIN Number	TW0004162003
SIC Code	2836

Key Executives

Name	Position
Hong-Ren Wang Ph.D.	President and Chief Executive Officer
Jose Hsieh	Senior Manager of Accounting
Chi-Hsing Chang	Vice President of Corporate Development
Melody Lin	Director of Human Resources